Beta thalassemia cardiomyopathy

Jump to navigation Jump to search

WikiDoc Resources for Beta thalassemia cardiomyopathy

Articles

Most recent articles on Beta thalassemia cardiomyopathy

Most cited articles on Beta thalassemia cardiomyopathy

Review articles on Beta thalassemia cardiomyopathy

Articles on Beta thalassemia cardiomyopathy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Beta thalassemia cardiomyopathy

Images of Beta thalassemia cardiomyopathy

Photos of Beta thalassemia cardiomyopathy

Podcasts & MP3s on Beta thalassemia cardiomyopathy

Videos on Beta thalassemia cardiomyopathy

Evidence Based Medicine

Cochrane Collaboration on Beta thalassemia cardiomyopathy

Bandolier on Beta thalassemia cardiomyopathy

TRIP on Beta thalassemia cardiomyopathy

Clinical Trials

Ongoing Trials on Beta thalassemia cardiomyopathy at Clinical Trials.gov

Trial results on Beta thalassemia cardiomyopathy

Clinical Trials on Beta thalassemia cardiomyopathy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Beta thalassemia cardiomyopathy

NICE Guidance on Beta thalassemia cardiomyopathy

NHS PRODIGY Guidance

FDA on Beta thalassemia cardiomyopathy

CDC on Beta thalassemia cardiomyopathy

Books

Books on Beta thalassemia cardiomyopathy

News

Beta thalassemia cardiomyopathy in the news

Be alerted to news on Beta thalassemia cardiomyopathy

News trends on Beta thalassemia cardiomyopathy

Commentary

Blogs on Beta thalassemia cardiomyopathy

Definitions

Definitions of Beta thalassemia cardiomyopathy

Patient Resources / Community

Patient resources on Beta thalassemia cardiomyopathy

Discussion groups on Beta thalassemia cardiomyopathy

Patient Handouts on Beta thalassemia cardiomyopathy

Directions to Hospitals Treating Beta thalassemia cardiomyopathy

Risk calculators and risk factors for Beta thalassemia cardiomyopathy

Healthcare Provider Resources

Symptoms of Beta thalassemia cardiomyopathy

Causes & Risk Factors for Beta thalassemia cardiomyopathy

Diagnostic studies for Beta thalassemia cardiomyopathy

Treatment of Beta thalassemia cardiomyopathy

Continuing Medical Education (CME)

CME Programs on Beta thalassemia cardiomyopathy

International

Beta thalassemia cardiomyopathy en Espanol

Beta thalassemia cardiomyopathy en Francais

Business

Beta thalassemia cardiomyopathy in the Marketplace

Patents on Beta thalassemia cardiomyopathy

Experimental / Informatics

List of terms related to Beta thalassemia cardiomyopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Untreated thalassemia Major eventually leads to death usually by heart failure, therefore birth screening is very important. β-Thalassemia cardiomyopathy takes on two phenotypes:

Dilated phenotype: Left ventricular dilatation and impaired contractility are present
Restrictive phenotype: Restrictive left ventricular filling is present along with pulmonary hypertension, and right heart failure.

The pathophysiology of β-Thalassemia cardiomyopathy is multifactorial, with myocardial iron overload and immunoinflammatory processes being the predominant mechanisms.

Template:WH Template:WS